India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the Read the full story

Novartis , the world's biggest pharmaceutical (big pharma) company, recently increased its interest in Israel to sign pharma deals. For a long time, the company was active in marketing and clinical trials in Israel, and now it is involved in investment as well. Read the full story

M&A hunt: Speaking at the Leerink Swann Global Healthcare Conference last week, James Foster, chief executive officer of Charles River Laboratories, indicated the company was actively looking for merger and acquisition targets in 2015. Read the full story

Read the full story

Biotech rumor mill: Helix BioPharma Corp. announced Friday that it has begun “a comprehensive exploration of growth opportunities,” code that most of the biotech market has taken to mean the company has a shopping list of potential acquisitions and will be buying snap-on targets soon. Read the full story

Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets  that it is looking for further takeover pharma deals. Read the full story

Arbor Pharmaceuticals LLC is allegedly exploring a potential acquisition and merger partner that could bring in more than $1 billion, according to people who are close to the situation.

Read the full story

Pfizer Inc. has approached Actavis with a possibility to acquire the company. Read the full story

Akorn targets UCB's subsidiary for acquisition for tax inversion. Read the full story

Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials Read the full story